Morton Brown Family Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Morton Brown Family Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21K	Hold	5	–	–	﹤0.01%	292
2026 Q1	$945	Hold	5	–	–	﹤0.01%	270
2025 Q4	$850	Hold	5	–	–	﹤0.01%	277
2025 Q3	$659	Hold	5	–	–	﹤0.01%	251
2025 Q2	$531	Hold	5	–	–	﹤0.01%	294
2025 Q1	$621	Hold	5	–	–	﹤0.01%	298
2024 Q4	$616	Hold	5	–	–	﹤0.01%	258
2024 Q3	$557	Hold	5	–	–	﹤0.01%	248
2024 Q2	$544	Hold	5	–	–	﹤0.01%	208
2024 Q1	$602	Hold	5	–	–	﹤0.01%	202
2023 Q4	$615	Buy	+5	New	+$624	﹤0.01%	267

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Morton Brown Family Wealth's JAZZ Position: Q2 2026 in Review

Morton Brown Family Wealth held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 5 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #292.

Morton Brown Family Wealth first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. 164 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Morton Brown Family Wealth held 5 shares of Jazz Pharmaceuticals worth $1.21K as of Q2 2026.
Morton Brown Family Wealth left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #292 holding.
Morton Brown Family Wealth first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
164 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.